MyDx (MYDX) Stock Price, News & Analysis

Company Overview

MyDx, Inc. (OTCMKTS: MYDX) develops and markets portable diagnostic devices designed for rapid, on-the-spot chemical analysis. The company’s flagship offering, the MyDx Analyzer, pairs a handheld sensor unit with disposable test tubes to detect and quantify compounds in breath and liquid samples. Through an accompanying mobile application, users can access real-time analytical data, making the system suitable for personal, professional, and industrial applications.

MyDx’s product lineup includes specialized testing kits for cannabis potency, alcohol levels, food safety contaminants, environmental pollutants and veterinary drug residues. By leveraging proprietary sensor technology and cloud-based software, the company enables users—from medical cannabis patients and law enforcement agencies to food processors—to obtain lab-grade results in minutes without the need for centralized laboratory equipment.

Headquartered in San Diego, California, MyDx distributes its devices and test kits primarily across North America through an e-commerce platform and select retail partners. The company holds patents on key aspects of its sensor and data management technologies and pursues licensing agreements to extend its analytical capabilities into new markets. MyDx’s mission centers on democratizing chemical testing by making it accessible, affordable and user-friendly outside traditional laboratory settings.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 900,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Technology
• Industry: Electronic Equipment, Instruments & Components
• Sub-Industry: Electronic Equipment & Instruments
• Current Symbol: OTCMKTS:MYDX
• CIK: 1582341
• Web: www.mydxlife.com
• Phone: (800) 814-4550
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A